Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 34Terminated 16Recruiting 13Not yet recruiting 4Active not recruiting 4Unknown 3Withdrawn 2No longer available 1

Sponsor Class

OTHER 38INDUSTRY 4OTHER_GOV 2NETWORK 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Plasma cell 1

Conditions

Breast Neoplasms 2Neoplasm Metastasis 1Multiple Myeloma 1

Interventions

Injections 39Carboplatin 33Capecitabine 24Paclitaxel 23Cisplatin 23Docetaxel 22pembrolizumab 21Oxaliplatin 21Gemcitabine 21Bevacizumab 19Pemetrexed 18Fluorouracil 13Irinotecan 12Cyclophosphamide 11osimertinib 9Nivolumab 9Dexamethasone 8Topotecan 7Leucovorin 7130-nm albumin-bound paclitaxel 7venetoclax 6toripalimab 6tislelizumab 6regorafenib 6lenvatinib 6fludarabine 6Doxorubicin 6Cetuximab 6daratumumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Standard of Care × Clear all
NCT07563595 2026-05-04

ELENI

iOMEDICO AG

Not yet recruiting
500 enrolled
Breast

Breast Neoplasms

NCT07181239 2025-09-18

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

Keymed Biosciences Co.Ltd

Phase 3 Not yet recruiting
280 enrolled
Plasma cell

Multiple Myeloma

NCT06309615 2025-05-29

PDxBRUTILITY

Precise Dx, Inc.

Not yet recruiting
300 enrolled
Breast

Breast Neoplasms

NCT06961188 2025-05-07

Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
174 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡